How big is the Japan Self-Monitoring Blood Glucose Devices Market?

The Japan Self-Monitoring Blood Glucose Devices Market size is expected to reach USD 663.13 million in 2024 and grow at a CAGR of 5.60% to reach USD 851 million by 2029. Read More

What is the current Japan Self-Monitoring Blood Glucose Devices Market size?

In 2024, the Japan Self-Monitoring Blood Glucose Devices Market size is expected to reach USD 663.13 million. Read More

Who are the key players in Japan Self-Monitoring Blood Glucose Devices Market?

Roche Diabetes Care, Abbott Diabetes Care, LifeScan, Nipro and Arkray are the major companies operating in the Japan Self-Monitoring Blood Glucose Devices Market. Read More

What years does this Japan Self-Monitoring Blood Glucose Devices Market cover, and what was the market size in 2023?

In 2023, the Japan Self-Monitoring Blood Glucose Devices Market size was estimated at USD 625.99 million. The report covers the Japan Self-Monitoring Blood Glucose Devices Market historical market size for years: 2018, 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Japan Self-Monitoring Blood Glucose Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Japan Self-Monitoring Blood Glucose Devices Companies

This report lists the top Japan Self-Monitoring Blood Glucose Devices companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Japan Self-Monitoring Blood Glucose Devices industry.